Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms

被引:14
|
作者
van der Merwe, Jacques Q.
Moreau, France
MacNaughton, Wallace K. [1 ]
机构
[1] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada
基金
加拿大健康研究院;
关键词
ion transport; proteases; signal transduction; epidermal growth factor receptor; cRaf; KINASE-C-DELTA; COLONIC-MUCOSA HYPERPROLIFERATION; SIGNAL-REGULATED KINASE; MOLECULAR-CLONING; SMOOTH-MUSCLE; CALU-3; CELLS; SECRETION; CFTR; EXPRESSION; ERK;
D O I
10.1152/ajpgi.90425.2008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
van der Merwe JQ, Moreau F, MacNaughton WK. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms. Am J Physiol Gastrointest Liver Physiol 296: G1258-G1266, 2009. First published April 9, 2009; doi:10.1152/ajpgi.90425.2008.-Serine proteases play important physiological roles through their activity at G protein-coupled protease-activated receptors (PARs). We examined the roles that specific phospholipase (PL) C and protein kinase (PK) C (PKC) isoforms play in the regulation of PAR(2)-stimulated chloride secretion in intestinal epithelial cells. Confluent SCBN epithelial monolayers were grown on Snapwell supports and mounted in modified Ussing chambers. Short-circuit current (I-sc) responses to basolateral application of the selective PAR(2) activating peptide, SLIGRL-NH2, were monitored as a measure of net electrogenic ion transport caused by PAR(2) activation. SLIGRL-NH2 induced a transient I-sc response that was significantly reduced by inhibitors of PLC (U73122), phosphoinositol-PLC (ET-18), phosphatidylcholine-PLC (D609), and phosphatidylinositol 3-kinase (PI3K; LY294002). Immunoblot analysis revealed the phosphorylation of both PLC beta and PLC gamma following PAR(2) activation. Pretreatment of the cells with inhibitors of PKC (GF 109203X), PKC alpha/beta I (Go6976), and PKC delta (rottlerin), but not PKC zeta (selective pseudosubstrate inhibitor), also attenuated this response. Cellular fractionation and immunoblot analysis, as well as confocal immunocytochemistry, revealed increases of PKC beta I, PKC delta, and PKC epsilon, but not PKC alpha or PKC zeta, in membrane fractions following PAR(2) activation. Pretreatment of the cells with U73122, ET-18, or D609 inhibited PKC activation. Inhibition of PI3K activity only prevented PKC delta translocation. Immunoblots revealed that PAR(2) activation induced phosphorylation of both cRaf and ERK1/2 via PKC delta. Inhibition of PKC beta I and PI3K had only a partial effect on this response. We conclude that basolateral PAR(2)-induced chloride secretion involves activation of PKC beta I and PKC delta via a PLC-dependent mechanism resulting in the stimulation of cRaf and ERK1/2 signaling.
引用
收藏
页码:G1258 / G1266
页数:9
相关论文
共 50 条
  • [41] Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2
    Miike, S
    McWilliam, AS
    Kita, H
    JOURNAL OF IMMUNOLOGY, 2001, 167 (11): : 6615 - 6622
  • [42] Activation of protease-activated receptor-2 (PAR-2) induces cardioprotection in anaesthetised mice
    Lim, SY
    Kane, KA
    Kennedy, S
    Wainwright, CL
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 858 - 858
  • [43] Protease-Activated Receptor-2: A Multifaceted Molecular Transducer in the Human
    Andersen, Hjalte H.
    ANNALS OF DERMATOLOGY, 2016, 28 (06) : 771 - 772
  • [44] Protease-activated receptor-2 in rat pancreatic stellate cells
    Masamune, A
    Kikuta, K
    Suzuki, N
    Satoh, M
    Shimosegawa, T
    GASTROENTEROLOGY, 2004, 126 (04) : A596 - A596
  • [45] Protease-activated receptor-2 augments experimental crescentic glomerulonephritis
    Moussa, Leon
    Apostolopoulos, Jim
    Davenport, Piers
    Tchongue, Jorge
    Tipping, Peter G.
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (03): : 800 - 808
  • [46] Protease-activated receptor-2 downregulation is associated to vitiligo lesions
    Moretti, Silvia
    Nassini, Romina
    Prignano, Francesca
    Pacini, Alessandra
    Materazzi, Serena
    Naldini, Antonella
    Simoni, Antonella
    Baroni, Gianna
    Pellerito, Silvia
    Filippi, Irene
    Lotti, Torello
    Geppetti, Pierangelo
    Massi, Daniela
    PIGMENT CELL & MELANOMA RESEARCH, 2009, 22 (03) : 335 - 338
  • [47] Fracture healing in protease-activated receptor-2 deficient mice
    O'Neill, Kevin R.
    Stutz, Christopher M.
    Mignemi, Nicholas A.
    Cole, Heather
    Murry, Matthew R.
    Nyman, Jeffry S.
    Hamm, Heidi
    Schoenecker, Jonathan G.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (08) : 1271 - 1276
  • [48] Role of Protease-activated Receptor-2 in Idiopathic Pulmonary Fibrosis
    Wygrecka, Malgorzata
    Kwapiszewska, Grazyna
    Jablonska, Ewa
    von Gerlach, Susanne
    Henneke, Ingrid
    Zakrzewicz, Dariusz
    Guenther, Andreas
    Preissner, Klaus T.
    Markart, Philipp
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (12) : 1703 - 1714
  • [49] CORRELATION OF SYNOVITIS WITH PROTEASE-ACTIVATED RECEPTOR-2 EXPRESSION IN OSTEOARTHRITIS
    Kelso, Elizabeth B.
    Ferrell, William R.
    Lockhart, John C.
    Walsh, David A.
    Gracie, Alastair J.
    McInnes, Iain B.
    RHEUMATOLOGY, 2009, 48 : I5 - I5
  • [50] Molecular cloning of a protease-activated receptor-2 subtype.
    Compton, SJ
    Cairns, JA
    Palmer, KJ
    Gough, AC
    Darley, M
    Walls, AF
    FASEB JOURNAL, 1999, 13 (04): : A325 - A325